These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 11584742)
1. Drug studies in developing countries. Olliaro PL; Vijayan R; Inbasegaran K; Lang CC; Looareesuwan S Bull World Health Organ; 2001; 79(9):894-5. PubMed ID: 11584742 [No Abstract] [Full Text] [Related]
3. More drugs, less protection. Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521 [No Abstract] [Full Text] [Related]
4. Pharmaceutical research: paradox, challenge or dilemma? Sheikh AL East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688 [TBL] [Abstract][Full Text] [Related]
5. TRIPS, pharmaceuticals, developing countries, and the Doha "solution". Sykes AO Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299 [No Abstract] [Full Text] [Related]
6. Freebies for subject 641: a discussion of the ethical prospect of providing drug trial subjects with post-trial access to the drug tested--a Canadian perspective. Hutt LE Health Law J; 1998; 6 Spec No():169-87. PubMed ID: 14746066 [TBL] [Abstract][Full Text] [Related]
7. An audience with... Victoria G. Hale. Hale VG Nat Rev Drug Discov; 2005 Nov; 4(11):878. PubMed ID: 16299916 [No Abstract] [Full Text] [Related]
8. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases. Hentschel CC Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625 [No Abstract] [Full Text] [Related]
9. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
10. Medicines for the world: a way forward. James JS AIDS Treat News; 2004 Mar; (399):7-8. PubMed ID: 15199870 [TBL] [Abstract][Full Text] [Related]
11. EU agrees deal on cheaper drugs for developing world. Watson R BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716 [No Abstract] [Full Text] [Related]
12. Access to medicines report cards. Mullard A Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336 [No Abstract] [Full Text] [Related]
13. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines. Tetteh E Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829 [No Abstract] [Full Text] [Related]
14. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
15. Making drugs, not profits. Stix G Sci Am; 2004 May; 290(5):42-4. PubMed ID: 15127660 [No Abstract] [Full Text] [Related]
16. Use caution when donating drugs, guidelines suggest. Riggs B CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855 [No Abstract] [Full Text] [Related]
17. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS. Curti AM Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145 [No Abstract] [Full Text] [Related]
18. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
19. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations. Kelleher F Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695 [TBL] [Abstract][Full Text] [Related]
20. WHO and industry combine to form ethics body. Dickson D Nat Med; 2002 Jul; 8(7):645. PubMed ID: 12091885 [No Abstract] [Full Text] [Related] [Next] [New Search]